#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pustular psoriasis Metabolic disorder Acute graft versus host disease in skin Cardiomyopathy Cholangiosarcoma Carcinoid tumour Extra-osseous Ewing's sarcoma recurrent Fms-like tyrosine kinase 3 positive Colon cancer Familial haemophagocytic lymphohistiocytosis Pancreatic neuroendocrine tumour Post transplant lymphoproliferative disorder Deafness Chondrodystrophy Rosai-Dorfman syndrome More trials…

    Learn about Rare Diseases

    Friedreich’s ataxia – Diagnostics Cystic fibrosis lung – Trials in Disease Phenylketonuria – Treatment Behcet’s syndrome – Life with Disease Thrombotic thrombocytopenic purpura – Life with Disease Congenital generalised lipodystrophy – Diagnostics Lymphangioma – Life with Disease Stevens-Johnson syndrome – Trials in Disease Paraneoplastic neurological syndrome – Treatment Alagille syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dopamine Hydrochloride Warfarin Gallium (68Ga) Gozetotide Envudeucitinib Bi 3720931 Suxamethonium Chloride Itepekimab Zinc Sulphate Heptahydrate Patritumab Deruxtecan Xenon Dapansutrile Mifepristone POLYSORBATE 80 Elenestinib Phosphate Abelacimab Cortisone Acetate Bendamustine Hydrochloride Reparixin Bempedoic Acid Tocotrienol More therapies…

    Learn about Your Condition

    Obsessive-compulsive disorder Immune thrombocytopenia Fracture infection Candida infection Milk allergy Merycism Hysterectomy Uterine leiomyosarcoma Systemic lupus erythematosus Magnetic resonance imaging Bronchopulmonary aspergillosis Haemorrhage intracranial Pneumothorax Leukocyte adhesion deficiency Bladder cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetic foot

  • Study on the Use of Plasma Rich in Growth Factors for Treating Foot Ulcers in Diabetic Patients with Peripheral Arterial Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic foot
    • Osteomyelitis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Cefalexin Monohydrate
    • Flucloxacillin
    Finland

  • Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Aup1602-C
    Italy

  • Study on the Safety and Effects of Udonitrectag for Treating Diabetic Foot Ulcers in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • UDONITRECTAG
    Italy

  • Study on the Effectiveness of Autologous Bone Marrow-Derived Mononuclear Cells and Angioplasty in Diabetic Patients with Chronic Limb-Threatening Ischemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR CELLS
    Czechia

  • Study Comparing Propylene Glycol and Urea Creams for Treating Dry Feet in People with Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Propylene Glycol
    • Urea
    Sweden
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!